Modeling long-QT syndromes with iPS cells

Journal of Cardiovascular Translational Research

Volumn 6, Issue 1, 2013, Pages 31-36

  Sinnecker, Daniel ^a   Goedel, Alexander ^a   Dorn, Tatjana ^a   Dirschinger, Ralf J ^a   Moretti, Alessandra ^a   Laugwitz, Karl Ludwig ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease modeling; iPS cells; Long QT syndrome; LQT; Reprogramming

Indexed keywords

ION CHANNEL; ISOPRENALINE; POTASSIUM CHANNEL; PROPRANOLOL; UNCLASSIFIED DRUG; VOLTAGE GATED ION CHANNEL;

AKAP9 GENE; ANK2 GENE; ARTICLE; CACNA1C GENE; CAV3 GENE; EARLY AFTERDEPOLARIZATION; ELECTROCARDIOGRAPHY MONITORING; GENE; GENE MUTATION; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART RATE; HUMAN; KCNE1 GENE; KCNE2 GENE; KCNH2 GENE; KCNJ GENE; KCNJ5 GENE; KCNQ1 GENE; LONG QT SYNDROME; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QT PROLONGATION; SCN4B GENE; SCN5A GENE; SNTA1 GENE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELLS, CULTURED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ION CHANNELS; LONG QT SYNDROME; MYOCYTES, CARDIAC; PHENOTYPE; RISK ASSESSMENT; TOXICITY TESTS;

IPS;

EID: 84872609379     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9416-1     Document Type: Article

References (32)

1. Ackerman, M. J; & Clapham, D. E. (2004). Excitability and Conduction. In K. R. Chen (Ed.), Molecular basis of cardiovascular disease: a companion to Braunwald's heart disease (2nd ed.). Philadelphia, USA: Saunders an Imprint of Elsevier.
2. Casimiro, M. C; Knollmann, B. C; Ebert, S. N; Vary, J. C; Jr; Greene, A. E; Franz, M. R; Grinberg, A; Huang, S. P; & Pfeifer, K. (2001). Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen syndrome. Proc. Natl. Acad. Sci. USA, 98(5), 2526-2531. (Pubitemid 32209515)
3. Dessertenne F. (1966) La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur, 59, 263-72.
4. Ebert, A. D; Yu, J; Rose, F. F; Jr; Mattis, V. B; Lorson, C. L; Thomson, J. A; & Svendsen, C. N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
5. Egashira, T; Yuasa, S; Suzuki, T; Aizawa, Y; Yamakawa, H; Matsuhashi, T; Ohno, Y; Tohyama, S; Okata, S; Seki, T; Kuroda, Y; Yae, K; Hashimoto, H; Tanaka, T; Hattori, F; Sato, T; Miyoshi, S; Takatsuki, S; Murata, M; Kurokawa, J; Furukawa, T; Makita, N; Aiba, T; Shimizu, W; Horie, M; Kamiya, K; Kodama, I; Ogawa, S; & Fukuda, K. (2012). Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovascular Research. doi: 10.1039/cvr/cvs206.
6. Fujiwara, M; Yan, P; Otsuji, T. G; Narazaki, G; Uosaki, H; Fukushima, H; Kuwahara, K; Harada, M; Matsuda, H; Matsuoka, S; Okita, K; Takahashi, K; Nakagawa, M; Ikeda, T; Sakata, R; Mummery, C. L; Nakatsuji, N; Yamanaka, S; Nakao, K; & Yamashita, J. K. (2011). Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One, 6(2), e16734.
7. Giorgi, M. A; Bolanos, R; Gonzalez, C. D; & Di Girolamo, G. (2010). QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications. Curr. Drug Safety, 5, 54-57.
8. Hattori, F; Chen, H; Yamashita, H; Tohyama, S; Satoh, Y. S; Yuasa, S; Li, W; Yamakawa, H; Tanaka, T; Onitsuka, T; Shimoji, K; Ohno, Y; Egashira, T; Kaneda, R; Murata, M; Hidaka, K; Morisaki, T; Sasaki, E; Susuki, T; Sano, M; Makino, S; Oikawa, S; & Fukuda, K. (2010). Nongenetic method for purifying stem cell-derived cardiomyocytes. Nature Methods, 7, 61-66.
9. Itzhaki, I; Maizels, L; Huber, I; Zwi-Dantsis, L; Caspi, O; Winterstern, A; Feldman, O; Gepstein, A; Arbel, G; Hammerman, H; Boulos, M; & Gepstein, L. (2011). Modelling the long-QT syndrome with induced pluripotent stem cells. Nature, 471(7337), 225-229.
10. Jung, C. B; Moretti, A; Mederos, Y; Schnitzler, M; Iop, L; Storch, U; Bellin, M; Dorn, T; Ruppenthal, S; Pfeiffer, S; Goedel, A; Dirschinger, R. J; Seyfarth, M; Lam, J. T; Sinnecker, D; Gudermann, T; Lipp, P; & Laugwitz, K.-L. (2011). Dantrolene rescues arrhythmogenic RYR defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Molecular Medicine, 4, 180-191.
11. Kannankeril, P. J; Roden, D. M; Norris, K. J; Whalen, S. P; George, A. L; Jr; & Murray, K. T. (2005). Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm, 2(2), 134-140. (Pubitemid 40220815)
12. Keller, G. M. (1995). In vitro differentiation of embryonic stem cells. Current Opinion in Cell Biology, 7(6), 862-869.
13. Kong, C. W; Akar, F. G; & Li, R. A. (2010). Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models. Thrombosis and Haemostasis, 104, 30-38.
14. Lahti, A. L; Kujala, V. J; Chapman, H; Koivisto, A.-P; Pekkanen-Mattila, M; Kerkelä, E; Hyttinen, J; Kontula, K; Swan, H; Conklin, B. R; Yamanaka, S; Silvennoinen, O; & Aalto-Setälä, K. (2012). Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Disease Models & Mechanisms, 5, 220-230.
15. Lasser, K. E; Allen, P. D; Woolhandler, S. J; Himmelstein, D. U; Wolfe, S. M; & Bor, D. H. (2002). Timing of new black box warnings and withdrawals for prescription medications. JAMA, 287, 2215-2220. (Pubitemid 34441937)
16. Lee, G; Papapetrou, E. P; Kim, H; Chambers, S. M; Tomishima, M. J; Fasano, C. A; Ganat, Y. M; Menon, J; Shimizu, F; Viale, A; Tabar, V; Sadelain, M; & Studer, L. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461, 402-406.
17. Lee, M. P; Ravenel, J. D; Hu, R.-J; Lustig, L. R; Tomaselli, G; Berger, R. D; Brandenburg, S. A; Litzi, T. J; Bunton, T. E; Limb, C; Francis, H; Gorelikow, M; Gu, H; Washington, K; Argani, P; Goldenring, J. R; Coffey, R. J; & Feinberg, A. P. (2000). Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. The Journal of Clinical Investigation, 106, 1447-1455. (Pubitemid 32038583)
18. Lehnart, S. E; Ackerman, M. J; Benson, W; Brugada, R; Clancy, C. E; Donahue, J. K; George, A. L; Jr; Grant, A. O; Groft, S. C; January, C. T; Lathrop, D. A; Lederer, J; Makielski, J. C; Mohler, P. J; Moss, A; Nerbonne, J. M; Olson, T. M; Przywara, D. A; Towbin, J. A; Wang, L.-H; & Marks, A. R. (2007). Inherited arrhythmias. A national heart, lung, and blood institute and office of rare diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation, 116, 2325-2345. (Pubitemid 350100339)
19. Malan, D; Friedrichs, S; Fleischmann, B. K; & Sasse, P. (2011). Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circulation Research, 109, 841-847.
20. Matsa, E; Rajamohan, D; Dick, E; Young, L; Mellor, I; Stainforth, A; & Denning, C. (2011). Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long-QT syndrome type 2 mutation. European Heart Journal, 32(8), 952-962.
21. Moretti, A; Bellin, M; Welling, A; Jung, C. B; Lam, J. T; Bott-Flügel, L; Dorn, T; Goedel, A; Höhnke, C; Hofmann, F; Seyfarth, M; Sinnecker, D; Schömig, A; & Laugwitz, K.-L. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. The New England Journal of Medicine, 363(15), 1397-1409.
22. Mummery, C. (2010). Sorting cardiomyocytes: a simple solution after all? Nat. Meth; 7, 40-42.
23. Nerbonne, J. M; Nichols, C. G; Schwarz, T. L; & Escande, D. (2001). Genetic manipulation of cardiac K + channel function in mice. What we have learned, and where do we go from here? Circulation Research, 89, 944-956. (Pubitemid 34649383)
24. Shafa, M; Sjonesen, K; Yamashita, A; Liu, S; Michalak, M; Kallos, M. S; & Rancourt, D. E. (2011). Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. Journal of Tissue Engineering and Regenerative Medicine. doi: 10.1002/term.450.
25. Takahashi, K; Tanabe, K; Ohnuki, M; Narita, M; Ichisaka, T; Tomoda, K. & Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-72. (Pubitemid 350138099)
26. Takahashi, K; & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676. (Pubitemid 44233629)
27. Wu, G; Ai, T; Kim, J. J; Mohapatra, B; Xi, Y; Li, Z; Abbasi, S; Purevjav, E; Samani, K; Ackerman, M. J; Qi, M; Moss, A. J; Shimizu, W; Towbin, J. A; Cheng, J; & Vatta, M. (2008). α 1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circulation. Arrhythmia and Electrophysiology, 1(3), 193-201.
28. Yang, Y; Yang, Y; Liang, B; Liu, J; Li, J; Grunnet, M; Olesen, S.-P; Rasmussen, H. B; Ellinor, P. T; Gao, L; Lin, X; Li, L; Wang, L; Xiao, J; Liu, Y; Liu, Y; Zhang, S; Liang, D; Peng, L; Jespersen, T; & Chen, Y.-H. (2010). Identification of a Kir3.4 mutation in congenital long QT syndrome. American Journal of Human Genetics, 86, 872-880.
29. Yazawa, M; Hsue, B; Jia, X; Pasca, A; Bernstein, J. A; Hallmayer, J; & Dolmetsch, R. E. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature, 471(7337), 230-234.
30. Ye, L; Chang, J. C; Lin, C; Sun, X; Yu, J; & Kan, Y. W. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA, 106(24), 9826-9830.
31. Yu, J; Vodyanìk, M. A; Smuga-Otto, K; Antosiewicz-Bourget, J; Frane, J. L; Tian, S; Nie, J; Jonsdottir, G. A; Ruotti, V; Stewart, R; Slukvin, I. I; & Thomson, J. A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917-1920.
32. Zhang, J; Wilson, G. F; Soerens, A. G; Koonce, C. H; Yu, J; Palecek, S. P; Thomson, J. A; & Kamp, T. J. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104, e30-e41.